Fundraising Fox

Alligator Bioscience

Lund, SE · Founded 2001 · 1 known investors

alligatorbioscience.se ↗

Alligator Bioscience is a clinical-stage biopharmaceutical company developing immunotherapies for cancer, with lead candidates such as mitazalimab being studied in tumors including breast and gastric cancer. The company is listed on Nasdaq Stockholm (ATORX).

BiotechHealthtech

Investors · 1

Sunstone CapitalFrederiksberg

In the news

Alligator Bioscience shares crash 73% after dropping key drug program By Investing.cominvesting.com · Jul 2026Alligator Discontinues Independent Development of Mitazalimab for a Strategic Refocus on the HLX22 Project, Announces a Rights Issue of Units of Approximately SEK 125.6 Million and Raises Bridge Loans | Morningstarmorningstar.com · Jul 2026Earnings call transcript: Alligator Bioscience’s strategic advancements in Q1 2026 By Investing.cominvesting.com · May 2026Alligator Bioscience AB Reports Financial Results for The Period 1 January – 31 March 2026 and Provides a Business Updateca.finance.yahoo.com · May 2026Alligator Bioscience Executives Back TO 14 Warrant Exercise, Potentially Raising SEK 49 Million - TipRanks.comtipranks.com · Mar 2026Alligator Bioscience AB Reports Full Year Financial Results for 2025 and for Q4 2025 and Provides a Business Updatefinance.yahoo.com · Feb 2026

Frequently asked questions

What does Alligator Bioscience do?
Alligator Bioscience is a clinical-stage biopharmaceutical company developing immunotherapies for cancer, with lead candidates such as mitazalimab being studied in tumors including breast and gastric cancer. The company is listed on Nasdaq Stockholm (ATORX).
Who are Alligator Bioscience's investors?
Alligator Bioscience's investors include Sunstone Capital.
Where is Alligator Bioscience headquartered?
Alligator Bioscience is headquartered in Lund, SE.